Country Trust Bank’s NovoCure NVCR Stock Holding History

Country Trust Bank’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500	Closed	-$6.46K	–	626
2025 Q4	$6.46K	Hold	500	–	–	﹤0.01%	386
2025 Q3	$6.46K	Hold	500	–	–	﹤0.01%	389
2025 Q2	$8.9K	Buy	+500	New	+$8.71K	﹤0.01%	321

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Country Trust Bank's NVCR Position: Q1 2026 in Review

Country Trust Bank sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 500 shares — an estimated $6.46K sold.

Country Trust Bank first reported a position in NVCR in Q2 2025 and held it in 3 quarters. The position peaked at $8.9K in Q2 2025. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Country Trust Bank reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
Country Trust Bank sold 500 NovoCure shares in Q1 2026, an estimated $6.46K.
Country Trust Bank first reported a position in NovoCure in Q2 2025 and held it in 3 quarters.
Country Trust Bank's NovoCure position peaked at $8.9K in Q2 2025.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Country Trust Bank's 13F filing for Q1 2026, filed 10 Apr 2026.